|
시장보고서
상품코드
2078222
백혈구 성분채집 장치 시장 : 장치 유형별, 용도별, 최종사용자별, 지역별Leukapheresis Devices Market, By Device Type, By Application, By End User, By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) |
||||||
백혈구 성분채집 장치 시장은 2026년에 3,780만 달러, 2033년까지 6,530만 달러에 이를 것으로 예상됩니다. 또한, 2026-2033년 CAGR 8.1%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 2026년 시장 규모 : | 3,780만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 8.10% | 2033년 시장 규모 예측 : | 6,530만 달러 |
백혈구 분리법이란, 혈액 검체에서 백혈구를 분리하는 의료 시술을 말합니다. 이 처치는 혈액 악성 종양을 앓고 있는 환자의 백혈구 수를 줄이기 위해 시행됩니다. 따라서, 백혈구 성분채집 장치란 이 처치를 용이하게 하기 위해 사용되는 의료기기를 말합니다. 임상 연구 분야에서 백혈구 팩(Leukopaks)에 대한 수요가 급증하고 있는 것은 시장 성장을 가속하는 주요 요인 중 하나입니다. 헌혈 관련 활동 증가와 더불어, 기술의 혁신과 발전 또한 시장 성장을 좌우하는 요인 중 하나입니다. 사람들의 건강에 대한 인식 제고, 백혈구(WBC) 분리 과정에 대한 승인 확대, 그리고 의료 관광 증가 역시 향후 수익성이 높은 성장 기회를 더욱 창출할 중요한 요인이 될 것입니다.
시장 역학
이 백혈구 성분채집 장치 시장 보고서에서는 최근 동향, 무역 규제, 수출입 분석, 생산 분석, 밸류체인 최적화, 시장 점유율, 국내 및 지역 시장의 주요 기업이 미치는 영향, 신흥 수익원에 대한 기회 분석, 시장 규제 변경, 전략적 시장 성장 분석, 시장 규모, 카테고리별 시장 성장, 용도별 틈새 시장 및 지배력, 제품 승인, 제품 출시, 지리적 확장, 그리고 시장의 기술 혁신에 대해 상세하게 설명하고 있습니다. 예를 들어, 2021년 12월, ExThera Medical사는 혈류 감염 치료 분야에서 충족되지 않은 임상적 요구를 해결하기 위한 획기적인 의료기기를 개발했으며, 아사히카세이 그룹의 핵심 사업자인 아사히카세이 메디컬은 ExThera사의 ‘Seraph 100 Microbind Affinity Blood Filter(Seraph 100)'에 대해 일본 내 독점 판매 계약을 체결했습니다. 본 계약의 틀에 따라, 엑셀라 메디컬과 아사히카세이 메디컬은 일본 국내에서 ‘Seraph 100'의 상용화를 위한 규제 당국의 승인을 얻기 위해 협력하게 됩니다. 전 세계 백혈구 성분채집 장치 시장은 백혈병 유병률 증가에 따라 예측 기간 동안 상당한 성장이 예상됩니다. 예를 들어, 2022년 6월, 혈액 성분, 치료용 아페레시스, 세포 기술 분야를 다루는 테르모 블러드와, 혈액 성분 채취, 치료용 아페레시스, 세포 기술용 제품, 소프트웨어, 서비스 포트폴리오를 전문으로 하는 의료 기술 기업인 셀 테크놀로지스는 바이오브리지·월드의 자회사인 젠큐어와 세포 및 유전자 치료 제조 솔루션을 확대 및 통합하기 위한 새로운 제휴 계약을 체결했다고 발표했습니다.
본 조사의 주요 특징:
- 본 조사에서는 다양한 부문에 걸친 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 다음의 매개변수(기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략)를 바탕으로 전 세계 백혈구 성분채집 장치 시장의 주요 기업 프로파일을 소개했습니다.
- 본 보고서를 통해 얻은 인사이트를 바탕으로, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기종 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- "세계 백혈구 성분채집 장치 시장” 보고서는 투자자, 공급업체, 제품 제조업체, 판매업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 백혈구 성분채집 장치 시장 분석에 활용된 다양한 전략 매트릭스를 활용함으로써 의사결정을 원활하게 진행할 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 백혈구 성분채집 장치 시장 : 장치 유형별, 2021년-2033년
제5장 세계의 백혈구 성분채집 장치 시장 : 용도별, 2021년-2033년
제6장 세계의 백혈구 성분채집 장치 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 백혈구 성분채집 장치 시장 : 지역별, 2021년-2033년
제8장 기업 개요
제9장 섹션
LSH 26.07.10Leukapheresis Devices Market is estimated to be valued at USD 37.8 Mn in 2026 and is expected to reach USD 65.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 37.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.10% | 2033 Value Projection: | USD 65.3 Mn |
Leukaemia is a medical procedure that involves separating white blood cells from a sample of blood. The procedure is undergone to reduce the quantity of white blood cells in patients wuth hematological malignancies. Therefore, leukapheresis devices are the medical devices that are used to facilitate this procedure. The surge in demand for leukopaks in clinical research is one of the major factors fostering the growth of the market. Growth in the number of activities associated with blood donations coupled with growing innovations and advancements in technologies is another market growth determinant. Rising health awareness among individuals, growing approvals for processes of isolating white blood cells (WBC), and rising medical tourism are other important factors that will further generate lucrative market growth opportunities.
Market Dynamics
This global leukapheresis devices market report provides details of recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, and technological innovations in the market. For instance, In December 2021, ExThera Medical develops revolutionary medical devices that address unmet clinical needs in the treatment of bloodstream infections and Asahi Kasei Medical, a core operating company of the Asahi Kasei Group, entered into an exclusive distribution agreement in Japan for ExThera's Seraph 100 Microbind Affinity Blood Filter (Seraph 100). As per the agreement structure, ExThera Medical and Asahi Kasei Medical will collaborate to obtain regulatory approval for Seraph 100 for commercialization in Japan. The global leukapheresis devices market is expected to witness significant growth during the forecast period, owing to the increasing prevalence of leukemia. For instance, in June 2022, Terumo Blood is in blood component, therapeutic apheresis and cellular technologies and Cell Technologies, a medical technology company specializing in a portfolio of products, software, and services for blood component collection, therapeutic apheresis, and cellular technologies, announced it had signed a new collaborative agreement with GenCure, a subsidiary of BioBridge Global, to extend and unify cell and gene therapy manufacturing solutions.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global leukapheresis devices market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Terumo BCT Inc., STEMCELL Technologies Inc., Fresenius SE & Co. KGaA, BioIVT, Grifols, S.A, HemaCare, B. Braun Melsungen AG, Caltag Medsystems Limited, AllCells, StemExpress, PPA, Cellero, Precision for Medicine, Inc., The Intelligent Tissue Group Lonza, BioIVT, Lmb Technologie GmbH, Kaneka Medical Europe N.V. and Key Biologics, LLC.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding its future product launches, type up-gradation, market expansion, and marketing tactic
- The global leukapheresis devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global leukapheresis devices market
Detailed Segmentation:
- Global Leukapheresis Devices Market, By Device Type (Revenue, USD Mn, 2021 - 2033)
- Apheresis Devices
- Leukapheresis Columns & Cell Separators
- Leukoreduction Filters
- Leukapheresis Disposables
- Global Leukapheresis Devices Market, By Application :
- Research Applications
- Therapeutic Applications
- Global Leukapheresis Devices Market, By End User:
- Hospitals
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Blood Component Providers
- Blood Centers
- Global Leukapheresis Devices Market , By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Asahi Kasei Medical Co. Ltd.
- Haemonetics Corporation
- Terumo BCT Inc.
- STEMCELL Technologies Inc.
- Fresenius SE & Co. KGaA
- BioIVT, Grifols, S.A
- HemaCare
- Braun Melsungen AG
- Caltag Medsystems Limited
- AllCells
- StemExpress
- PPA
- Cellero
- Precision for Medicine, Inc.
- The Intelligent Tissue Group Lonza
- BioIVT
- Lmb Technologie GmbH
- Kaneka Medical Europe N.V.
- Key Biologics, LLC.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Device Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaboration
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Leukapheresis Devices Market, By Device Type, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Apheresis Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Leukapheresis Columns & Cell Separators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Leukoreduction Filters
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
- Leukapheresis Disposables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Mn)
5. Global Leukapheresis Devices Market, By Application, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Therapeutic Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Leukapheresis Devices Market, By End User, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Academic & Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Blood Component Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Blood Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Leukapheresis Devices Market, By Region, 2021-2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- North America
- Introduction
- Market Size and Forecast, By Device Type, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Application, 2021-2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, By Device Type, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Application, 2021-2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Device Type, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Application, 2021-2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, By Device Type, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Application, 2021-2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, By Device Type, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Application, 2021-2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country, 2021-2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Device Type, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Application, 2021-2033, (US$ Mn)
- Market Size and Forecast, By End User, 2021-2033, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2021-2033, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Rest of Africa
8. Company Profiles
- Asahi Kasei Medical Co. Ltd.*
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Haemonetics Corporation
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Terumo BCT Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- STEMCELL Technologies Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Fresenius SE & Co. KGaA
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- BioIVT
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Grifols, S.A
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- HemaCare
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Braun Melsungen AG
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Caltag Medsystems Limited
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- AllCells
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- StemExpress
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PPA
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cellero
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Precision for Medicine, Inc.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- The Intelligent Tissue Group Lonza
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Lmb Technologie GmbH
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kaneka Medical Europe N.V.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Key Biologics, LLC.
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
9. Section
- Analyst view
- References
- Research Methodology
